Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy.

Kang, Yong Jin; Jang, Won Sik; Kwon, Jong Kyou; Yoon, Cheol Yong; Lee, Joo Yong; Ham, Won Sik; Choi, Young Deuk

Kang, Yong Jin; Jang, Won Sik; Kwon, Jong Kyou; Yoon, Cheol Yong; Lee, Joo Yong; Ham, Won Sik; Choi, Young Deuk.

Afiliação

Kang YJ; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea.
Jang WS; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea.
Kwon JK; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea.
Yoon CY; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea.
Lee JY; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea.
Ham WS; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea.
Choi YD; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea. youngd74@yuhs.ac.

BMC Cancer ; 17(1): 789, 2017 Nov 23.

Article em En | MEDLINE | ID: mdl-29169347

Assuntos

Biomarcadores Tumorais; Antígeno Prostático Específico/sangue; Neoplasias de Próstata Resistentes à Castração/sangue; Neoplasias de Próstata Resistentes à Castração/diagnóstico; Antineoplásicos Hormonais/uso terapêutico; Seguimentos; Meia-Vida; Humanos; Estimativa de Kaplan-Meier; Masculino; Terapia Neoadjuvante; Gradação de Tumores; Estadiamento de Neoplasias; Prognóstico; Modelos de Riscos Proporcionais; Prostatectomia; Neoplasias de Próstata Resistentes à Castração/mortalidade; Neoplasias de Próstata Resistentes à Castração/terapia

Palavras-chave

Neoadjuvant androgen deprivation therapy; Prostate; Prostate-specific antigen

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google